Clinical Trial Update: Identification of Volatile Organic Compounds (VOCs) as Biopredictors of Epileptic Seizures

View source ↗

Summary

A clinical trial is evaluating volatile organic compounds as biopredictors of epileptic seizures and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Snippet

Sponsor: Fondation Ophtalmologique Adolphe de Rothschild | Conditions: Epilepsy | Status: RECRUITING